|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Northern Ireland Centre of Food and Health2 Biomedical Sciences Research Institute, University of Ulster, Coleraine, UK 3 Danish Institute of Agricultural Sciences, Research Centre Foulum, Denmark 4 Rowett Research Institute, Aberdeen, UK
| Abstract |
|---|
|
|
|---|
(Received 11 August 2005;
accepted after revision 31 October 2005; first published online 1 November 2005)
Corresponding author V. Lesniewska: NICHE, School of Biomedical Sciences, University of Ulster, Cromore Road, Coleraine, Co. Londonderry, BT52 1SA, UK. Email: v.lesniewska{at}ulster.ac.uk
| Introduction |
|---|
|
|
|---|
More recent studies on the relationship between intestinal motility and intestinal microflora demonstrated a further complexity. It has been shown that inoculation of germ-free (GF) rats with conventional microflora shortened the duration of MMC cycles by over 50% and that the phase III migrated further aborally (Husebye et al. 1994). More importantly, the same researchers showed that the characteristics of MMC activity were different depending on the species of bacteria used to inoculate GF rats. In rats inoculated with Lactobacillus acidophilus A10 and Bifidobacterium bifidum B11 the duration of MMC cycles was decreased compared to that observed in control GF animals, whereas in rats inoculated with Micrococcus luteus and Escherichia coli X7 the duration of the MMC cycles was increased compared to that observed in control GF rats (Husebye et al. 2001). The results of the above studies from GF animals indicate that the gut motility response can depend on the composition of the intestinal microflora. However, the effect of the changes in the composition of the microflora that can be observed with increasing age in animals and humans (Benno et al. 1992; Woodmansey et al. 2004) or induced by dietary manipulation (Apajalahti et al. 2001; Naughton et al. 2001; Mikkelsen et al. 2004; Hedemann et al. 2005) on the intestinal motility is unknown.
There is no available method for in vitro evaluation of intestinal MMC, and to date research relies on direct or indirect in vivo methods of motility measurement. Hitherto, these methods have required the restraint of experimental animals. However, intestinal motility is significantly inhibited by experimentally applied restraint in the rat (Brown & Groves, 1966; Tsukada et al. 2000). Therefore, we propose a radiotelemetry method for the evaluation of the intestinal myoelectric activity in freely moving rats as method for studying the effect of diet and the bacteria on gastrointestinal motility. Radiotelemetry combines miniature sensors and transmitters to detect biological signals in animals and to broadcast signals to a remote receiver without a need for animal handling and restraint. Therefore, an in vivo model system which allows the evaluation of the intestinal motility without the need for restraint (and the resultant stress) provides a distinct scientific advantage, as was previously shown in GI tract research in pigs (Gacsalyi et al. 2000).
In this study, the radiotelemetry method was implemented to investigate whether dietary-induced changes in the intestinal microflora population affect small intestinal motility in the conventional state. Sixteen-month-old rats with normal bacteria were fed a diet supplemented with a mixture of prebiotic, an oligofructose-enriched inulin in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis, and its effect on the gut motility was evaluated.
| Methods |
|---|
|
|
|---|
Lactobacillus delbrueckii ssp. rhamnosus strain GG (LGG) and Bifidobacterium lactis Bb12 (Bb12) were provided by Valio (Helsinki, Finland) and purchased from Chr. Hansen (Horsholm, Denmark), respectively. They were supplied as a freeze-dried powder that contained 1 x 1013 to 2 x 1013 CFU g1 in the case of LGG and
5 x 1011 CFU g1 in the case of Bb12. For the purpose of the experiment, the concentration of LGG and Bb12 of different batches was evaluated by dissolving 0.1 g of the powder in 10 ml of Maximum Recovery Diluent (MRD; Oxoid, Basingstoke, UK). Serial dilutions were prepared using the same diluent and plating them on Rogosa agar (Oxoid) containing glacial acetic acid (1.32 ml l1) for lactobacilli and a selective media for bifidobacteria [BSM; Rogosa agar containing 0.05% (w/v) cysteine hydrochloride (Sigma, Gillingham, UK) and 50 mg l1 of Mupirocin (Oxoid)] as described by Leuschner et al. (2003). Plates were incubated in an anaerobic cabinet at 37°C: Rogosa agar plates for 48 h and BSM plates for 72 h. When the two strains were plated together (Wilkins Chalgren agar; Oxoid) they were easily recognizable as LGG forms large colonies, whereas those of Bb12 are pinpoint in size.
Animals and diets
All management and experimental procedures conducted during this study were performed in accordance with the European Community regulations concerning the welfare of experimental animals.
Control diet (AIN-93M synthetic meal rodent maintenance diet; Reeves et al. 1993) was purchased from Lillico, Betchworth, UK. Raftilose® Synergy1 (briefly Synergy1) food additive, an oligofructose-enriched inulin, was provided by ORAFTI (Tienen, Belgium). Synergy1 is a 1:1 mixture of long-chain and short-chain fractions of inulin, a ß(2-1)-fructan extracted from chicory roots (Cichorium intybus) as described elsewhere (Femia et al. 2002).
Thirty conventional SpragueDawley male rats, weighing 554 ± 7 g, were housed individually and kept in a temperature-controlled environment (22 ± 2°C) with a 12 h lightdark cycle. All rats were fed with AIN-93M rodent maintenance (control) diet at 4 g (100 g live body weight)1 24 h1. The daily amount of the diet per gram of rat was estimated based on the average initial body weight of the rats measured every week. After 2 weeks of adaptation, the diet of 15 randomly chosen rats (group E) was supplemented with 8% of Synergy1 and with LGG and Bb12 to provide 2.2 x 109 CFU of each strain per gram of the diet. The required amount of Synergy1, LGG and Bb12 was mixed with the daily diet allowance for each animal. The remaining rats (group C) were fed AIN-93M without supplements. All rats had free access to distilled water at all times. Food consumption was monitored daily and body weight was monitored weekly.
Experimental protocols
An overview of the experimental protocols is shown in Fig. 1. Seven days from the beginning of the treatment 12 rats were killed (6 animals for each feeding group), and various regions of gastrointestinal (GI) tract were sampled for microbiological analyses. At the same time point, an additional six rats (3 randomly chosen animals from each feeding group) were surgically modified for intestinal smooth muscle electromyography (EMG) in vivo. After an additional 14 days of the experiment (21 days from the beginning of the treatment) 12 rats were killed and sampled for microbiological analyses. At the same time point, two 6 h recordings of intestinal EMG were carried out on each operated rat. Subsequently, operated rats from C group received feed supplements and rats from E group received only control diet for 1 week, since it has been shown elsewhere that different probiotic strains colonize rat gastrointestinal tract after 7 days of oral administration (Femia et al. 2002) and persist for up to 5 days following cessation of the oral administration (Locascio et al. 2001; Weese et al. 2003). An additional two 6 h recordings were carried out on each operated rat 1 week after the dietary change.
|
Under general anaesthesia of induced and maintained with 2% (v/v) of isoflurane (Baxter A/S, Allerød, Denmark) in a gas mixture of O2 and NO2 (at the ratio of 2 : 3), rats were implanted with a three-channel radiotelemetry transmitter (TL10M3-F50-EEE, DSI, St Paul, MN, USA), equipped with three bipolar electrodes, as previously described (Lesniewska et al. 2004). The animals were given a single dose of 0.03 mg kg1 buprenorphine (Temgesic, Schering-Plough, Brussels, Belgium) subcutaneously prior to the surgery and twice a day during the first 2 days after the surgery, for analgesia. The recovery from surgery was uneventful.
The EMG signals from the radiotelemetry transmitter were collected by a receiver (RPC1, DSI) placed under the animal's cage. The receiver was coupled to the analog output (DL10, DSI). Each of three signal channels was then amplified (BioAmp, ADInstruments, Melbourne, Australia), recorded and filtered with an analog-to-digital Mac-based data recording system (PowerLab 8e, ADInstruments), as previously described (Lesniewska et al. 2000). An example of the EMG recording obtained using radiotelemetry in a rat is shown in Fig. 2.
|
After completing the experimental protocol, the surgically modified rats were killed by isoflurane overdose and exsanguination. Postmortem examinations performed at the conclusion of the experiment revealed no signs of inflammation around the implanted electrodes and transmitters.
Tissue sampling
Prior to tissue sampling, food but not water was removed for 12 h from randomly chosen animals following 7 or 21 days of experimental treatment. The animals were then killed by isoflurane overdose and exsanguination. At death, the stomach, two specimens of small intestine i.e. jejunal sample (1020 cm from the pylorus) and ileal sample (10 cm segment ending 2 cm proximal to caecum), caecum and colon were removed for isolation and enumeration of bacteria.
Isolation and enumeration of bacteria
GI tract samples (tissues plus contents) were weighed, and homogenized on ice with a Janke-Kunkel (Ascher, Netherlands) Ultra-Turrax T25 homogenizer at 20 000 r.p.m. in MRD (Oxoid) to provide a 100 g l1 suspension, and serially diluted to 108 with the same diluent. Dilutions of the samples were then inoculated in duplicate onto selective and non-selective agars: Columbia agar (Oxoid) containing 5% (v/v) defibrinated horse blood (for total anaerobic bacteria); Rogosa agar (Oxoid) containing glacial acetic acid (1.32 ml l1; for lactobacilli); and MacConkey agar no. 3 (for enterobacteria). Plates for anaerobic incubation had been stored in an anaerobic environment for 48 h. Two selective media were used for enumeration of bifidobacteria: Wilkins Chalgren agar (Oxoid) containing acetic acid (1 ml l1) and Mupirocin (100 mg l1; Oxoid), as described by Rada et al. (1999), and BSM (Leuschner et al. 2003). Inoculated agar plates were incubated in an anaerobic cabinet (Don Whitey Scientific, Shipley, UK) at 37°C (Columbia agar and Rogosa agar plates for 48 h; both bifidobacteria selective media plates for 72 h), except for MacConkey agar plates, which were incubated aerobically (at 37°C for 18 h).
The number of total anaerobic bacteria, lactobacilli, enterobacteria and bifidobacteria in the random samples of the control and experimental diet, taken on a weekly basis, was evaluated by dissolving 1 g of the diet in 100 ml of MRD (Oxoid). Serial dilutions were prepared using the same diluent and plating them in duplicate onto selective and non-selective agars as described above.
Statistics
Statistical analyses were performed using the SPSS statistics package (v.11.0.1 for Windows; SPSS, Woking, UK). Diet group differences and time effects on bacterial counts were evaluated using two-factor independent measures analysis of variance (ANOVA), with the diet and the duration of feeding the diet as the main factors. A significant interaction between diet and time indicated that the effects of the diet and time were interdependent. Where appropriate, Tukey's post hoc test was used to compare the diet effect for each of the time points studied. The temporal and spatial parameters of the MMC were analysed separately for each electrode using the following model:
|
|
i is the effect of diet (non-supplemented or supplemented), ßj is the effect of time on each diet (7 or 21 days),
k is the effect of recording (first or second),
ß
ijk is the interaction between diet, time on diet and recording,
ßij the interaction between diet and time on diet, 
jk is the interaction between diet and recording, Uk is the random effect of animal (k = 1, . . . 6), and
ijkl represents the unexplained random error, where l represents the repetitions on each animal. Diet, time on diet, recoding and their interactions were not significant (P > 0.05) and thus not included in the final statistical model. Therefore, the final statistical model included the effect of diet (non-supplemented or supplemented) and random animal effect (in order to account for repeated measurements on the same animal). Because the preliminary analysis revealed no statistically significant differences in any of the parameters between the two dietary supplements groups, these data were pooled for comparison with the unsupplemented data. The level of statistical significance was assigned as P < 0.05 in all performed analyses. Data are expressed as means ± S.E.M.
| Results |
|---|
|
|
|---|
All rats appeared clinically healthy throughout the experiment. The mean food intake was 4.0 ± 0.1 g (100 g live body weight)1, and there were no differences in food consumption between and within dietary groups.
Microbiological studies
Figure 3 shows the counts of total anaerobe, lactobacilli, bifidobacteria and enterobacteria in the stomach, jejunum and ileum. Dietary supplementation significantly increased the number of bifidobacteria in the stomach (Fig. 3A) and the small intestine (Fig. 3B and C) after 7 days of treatment. Furthermore, the number of bifidobacteria in the stomach increased with the duration of the treatment, being significantly higher after 21 than after 7 days of dietary supplementation. In both jejunum (Fig. 3B) and ileum (Fig. 3C) the number of enterobacteria decreased following 21 days of dietary supplementation with synbiotics. Supplementation of the diet with synbiotics did not have any significant effect on the number of total anaerobes, nor lactobacilli in the stomach (Fig. 3A), or in small intestine (Fig. 3B and C).
|
|
Table 1 shows the temporal characteristics of the intestinal myoelectric activity in conscious, freely moving rats. In all rats, regardless of the dietary treatment, duodenojejunal myoelectric activity exhibited triple-phase MMC. The results in Table 1 demonstrate that dietary supplementation with synbiotics significantly shortened the duration of MMC cycles in both parts of the jejunum, i.e. 14 and 28 cm distal to pylorus. In both parts of the jejunum, the supplementation of the diet significantly decreased the duration of phase II of the MMC, while it did not change the duration of the phase I and phase III of the MMC. The durations of the duodenal MMC cycles and phases were not affected by the experimental treatment.
|
|
|
| Discussion |
|---|
|
|
|---|
In the present study the EMG measurement of the myoelectric activity of gastrointestinal small muscles in vivo was used to evaluate the characteristics of small intestinal motility. This method was one of the first to be developed (Szurszewski, 1969; Sarna, 1989), and it is still frequently used to investigate small intestinal motility, hence it has been shown that the force, duration and propagation of muscle contractions are directly related to amplitude, frequency and propagation of spike potentials (Szurszewski, 1987). In the present study we implemented a radiotelemetry technique that allows the quantification of intestinal EMG in freely moving, unrestrained rats. It was previously shown that radiotelemetry helps to exclude distress related to handling and restraining rats (for reviews see Kramer et al. 2001; Kramer & Kinter, 2003). Therefore, it is suggested that the use of the radiotelemetry allows the exclusion of both acute and chronic stress from experiments, and that the changes in the characteristics of intestinal MMC observed in the present study in rats were evoked by the experimental treatments and not by stress artefacts.
The use of radiotelemetry allowed the recording of intestinal EMG over a longer period of time during each recording session. Bränström & Hellström (1996) showed that, in order to reduce the variability of the MMC characteristics, a minimum of four MMC cycles and at least five phases III of the MMC should be recorded, i.e. approximately a minimum of 1.5 h of recording under the particular experimental conditions. In the present study we were able to record at least 6 h of interdigestive intestinal EMG, i.e. an average of 19 MMC cycles from each session on each animal. The reduction of the MMC variability, together with the fact that animals were used as their own controls, allowed a reduction in the number of the animals required for the experimental procedure (Festing, 1992). This is in agreement with the previous research results on measurements of different physiological functions when using the radiotelemetry technique in rats in vivo (Fraser et al. 2001).
In the present study the addition of the synbiotics to the diet produced significant changes in the temporal and spatial characteristics of the myoelectric activity of the small intestine. The duration of the jejunal MMC cycles was decreased at the expense of the shortening of phase II of the MMC. This suggests faster luminal transport in jejunum, hence the rate of the intestinal luminal passage depends on the migration rate of the MMC (Laplace & Roman, 1979). This is supported by the other MMC parameters obtained in the present study, i.e. higher migration velocity of phase III as well as higher frequency of response potentials of phase III observed in animals fed the diet supplemented with synbiotics. The increase in these two parameters of phase III indicate that the intestinal contractions during phase III occurred with higher frequency and were stronger, hence the amplitude and propagation of intestinal contraction is directly related to the frequency and propagation of spike potentials (Szurszewski, 1987). In the present study the supplementation of the diet with synbiotics significantly increased the aboral propagation ratio of phase III of the MMC, i.e. the contractions triggered in the duodenum migrated distally over significantly longer distances in the small intestine when rats were fed diet supplemented with synbiotics. This is in agreement with the results of the study by Huseby et al. (1994) on GF SpraqueDawley rats, in which the conventionalization of gut microflora resulted in an increase in the calculated propagation ration of phase III in the small intestine. Overall changes observed in phase III characteristics in the present study indicate that the addition of the synbiotics to the diet stimulated a more regular occurrence of intestinal contractions of higher amplitude. Lumen occlusive and regular contractions are more effective in propelling the residual food, debris, secretions and bacteria cells (Code & Marlett, 1975). Therefore, we suggest that the addition of the synbiotics to the diet improved the interdigestive intestinal motility function in the rats our study.
In the present study the supplementation of the diet with synbiotics produced changes in the intestinal myoelectric activity from the seventh day of the experimental treatment, corresponding to the time of the increase in number of bifidobacteria in all parts of GI tract of the rats fed diet supplemented with synbiotics (Figs 3 and 4). Furthermore, the increase in the number of bifidobacteria in rats fed E diet was most prominent (59%) when compared to other evaluated bacterial groups, e.g. 9 and 11% increases in the number of lactobacilli and total anaerobes, respectively. There are no published data available on the relationship between dietary-evoked changes in the composition of the commensal intestinal microflora and changes in the characteristics of intestinal motility. Husebye et al. (2001) have shown that Lactobacillus acidophillus A10 and Bifidobacterium bifidum B11 accelerated small intestinal motility and digesta transit of adult GF rats. It may be that both bacterial strains evoked a specific response in terms of intestinal motility. Results from previous studies on the relationship between microflora and the GI tract motility showed that bacterial fermentation products, i.e. short-chain fatty acids (SCFA) regulate gastric (Cuche et al. 2000), ileal (Kamath et al. 1988) and colonic motility (Yajima, 1985; Cherbut et al. 1998) via humoral factors and neural pathways. This may indicate that different profiles of SCFA resulting from changes in the microflora may be involved in the regulation of duodenojejunal motility observed in rats in the present study. This, however, requires further investigation. Following 21 days of experimental treatment of animals with synbiotics there was a decrease in the numbers of enterobacteria in small intestine. This decrease did not show a relationship with the changes observed in the intestinal motility characteristics over time. However, there was a time association with the increase in the number of lactobacilli and bifidobacteria in the GI tract of rats fed synbiotics. It has been shown in vitro and in vivo in GF animals that both bifidobacteria and lactobacilli possess antagonistic activity against opportunistic bacteria, e.g. E. coli, and potentially pathogenic enterobacteria (Itoh & Freter, 1989; Korshunov et al. 1999; Bevilacqua et al. 2003; Asahara et al. 2004; Pêna et al. 2005). Therefore, it is more likely that decreases in the number of enterobacteria were related to the increase in the number of bifidobacteria and lactobacilli rather than to motility changes observed in a gut of rats fed synbiotics in the present study.
In conclusion, employing the radiotelemetry technique permitted the accurate recording and analysis of intestinal EMG in freely moving, unrestrained rats. Furthermore, using the telemetry technique it was demonstrated that changes in the gastrointestinal microflora exhibited an intestinal motility response and, more importantly, that such changes can be initiated by the addition of synbiotics to the diet. Further work is necessary in order to identify the underlying mechanisms responsible for diet/bacterial-induced changes in gastrointestinal motility. These findings may be of some relevance to the treatment of gastrointestinal dysfunction, especially that related to ageing, and this model may provide a means of studying these diseases further.
| References |
|---|
|
|
|---|
Asahara
T, Shimizu
K, Nomoto
K, Hamabata
T, Ozawa
A
&
Takeda
Y (2004). Probiotic bifidobacteria protect mice from lethal infection with Shiga toxin-producing Escherichia coli O157: H7. Infect Immun
72, 22402247.
Benno Y, Nakao H, Uchida K & Mitsuoka T (1992). Impact of the advances in age on the gastrointestinal microflora of beagle dogs. J Vet Med Sci 54, 703706.[Medline]
Bevilacqua L, Ovidi M, Di Mattia E, Trovatelli LD & Canganella F (2003). Screening of Bifidobacterium strains isolated from human faeces for antagonistic activities against potentially bacterial pathogens. Microbiol Res 158, 179185.[CrossRef][Medline]
Bränström R & Hellström PM (1996). Characteristics of fasting and fed myoelectric activity in rat small intestine: evaluation by computer analysis. Acta Physiol Scand 158, 5362.[CrossRef][Medline]
Brown MS & Groves WG (1966). Intestinal propulsion in restrained and unrestrained rats. Proc Soc Exp Biol Med 121, 989995.[Medline]
Campbell
JM, Fahey
GC
Jr
&
Wolf
BW (1997). Selected indigestible oligosaccharides affect large bowel mass, cecal and fecal short-chain fatty acids, pH and microflora in rats. J Nutr
127, 130136.
Cherbut C, Ferrier L, Roze C, Anini Y, Blottiere H, Lecannu G & Galmiche JP (1998). Short-chain fatty acids modify colonic motility through nerves and polypeptide YY release in the rat. Am J Physiol 275, G1415G1422.
Code
CF
&
Marlett
JA (1975). The interdigestive myo-electric complex of the stomach and small bowel of dogs. J Physiol
246, 289309.
Cuche G, Cuber JC & Malbert CH (2000). Ileal short-chain fatty acids inhibit gastric motility by humoral pathway. Am J Physiol 279, G925G930.
Femia
AP, Luceri
C, Dolara
P, Giannini
A, Biggeri
A, Salvadori
M, Clune
Y, Collins
KJ, Paglierani
M
&
Caderni
G (2002). Antitumorigenic activity of the prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis on azoxymethane-induced colon carcinogenesis in rats. Carcinogenesis
23, 19531960.
Festing
MF (1992). The scope for improving the design of laboratory animal experiments. Lab Anim
26, 256268.
Fraser TB, Tutner SW, Mangos GJ, Ludbrook J & Whitworth JA (2001). Comparison of telemetric and tail-cuff pressure monitoring in adrenocorticotrophic hormone-treated rats. Clin Exp Pharmacol Physiol 28, 831835.[CrossRef][Medline]
Gacsalyi U, Zabielski R & Pierzynowski SG (2000). Telemetry facilitates long-term recording of gastrointestinal myoelectrical activity in pigs. Exp Physiol 85, 239241.[Abstract]
Gibson GR (1999). Dietary modulation of the human gut microflora using the prebiotics oligofructose and inulin. J Nutr 129, 1438S1441S.
Gibson GR, Beatty ER, Wang X & Cummings JH (1995). Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology 108, 975982.[CrossRef][Medline]
Hedemann
MS, Mikkelsen
LL, Naughton
PJ
&
Jensen
BB (2005). Effect of feed particle size and feed processing on morphological characteristics in the small and large intestine of pigs and on adhesion of Salmonella enterica serovar Typhimurium DT12 in the ileum in vitro. J Anim Sci
83, 15541562.
Husebye E, Hellström PM & Midtvedt T (1994). Intestinal microflora stimulates myoelectric activity of rat small intestine by promoting cyclic initiation and aboral propagation of migrating myoelectric complex. Dig Dis Sci 39, 946956.[CrossRef][Medline]
Husebye
E, Hellström
PM, Sundler
F, Chen
J
&
Midtvedt
T (2001). Influence of microbial species on small intestinal myoelectric activity and transit in germ-free rats. Am J Physiol Gastrointest Liver Physiol
280, G368G380.
Itoh
K
&
Freter
R (1989). Control of Escherichia coli populations by a combination of indigenous clostridia and lactobacilli in gnotobiotic mice and continuous-flow cultures. Infect Immun
57, 559565.
Kamath PS, Phillips SF & Zinsmeister AR (1988). Short-chain fatty acids stimulate ileal motility in humans. Gastroenterology 95, 14961502.[Medline]
Korshunov VM, Urtaeva ZA, Smeianov VV, Efimov BA, Sarkisov SE, Krymshokalova ZA, Bainov NA, Pikina AP & Korshunova OV (1999). The antagonistic activity of bifidobacteria in vitro and in vivo studied by using gnotobiological technology. Zh Mikrobiol Epidemiol Immunobiol 5, 7277.
Kramer
K
&
Kinter
LG (2003). Evaluation and applications of radiotelemetry in small laboratory animals. Physiol Genomics
13, 197205.
Kramer K, Kinter LG, Brockway BP, Voss HP, Remie R & Van Zutphen BL (2001). The use of radiotelemetry in small laboratory animals: recent advances. Contemp Top Lab Anim Sci 40, 816.[Medline]
Kruse HP, Kleessen B & Blaut M (1999). Effects of inulin on faecal bifidobacteria in human subjects. Br J Nutr 82, 375382.[Medline]
Laplace JP & Roman C (1979). Activity of the gastro-intestinal musculature and movements of digesta. Ann Rech Vét 4, 347353.
Lesniewska V, Laerke HN, Hedemann MS, Hojsgaard S, Pierzynowski SG & Jensen BB (2000). The effect of change of the diet and feeding regimen at weaning on duodenal myoelectrical activity in piglets. Anim Sci 71, 443451.
Lesniewska V, Laerke HN & Naughton P (2004). Application of radio-telemetry using DSI implants and equipment for gastrointestinal EMG recordings in rats. Telemetry Times 3, 5. [Online] http://www.datasci.com/references/ttimes/index.html
Leuschner RGK, Bew J, Simpson P, Ross PR & Stanton C (2003). A collaborative study of a method for enumeration of probiotic bifidobacteria in animal feed. Int J Food Microbiol 83, 161170.[CrossRef][Medline]
Locascio M, Pesce de Ruiz Holgado A, Perdigon G & Oliver G (2001). Enteric bifidobacteria: isolation form human infants and challenge studies in mice. Can J Microbiol 47, 10481052.[CrossRef][Medline]
Luyer
MD, Buurman
WA, Hadfoune
M, Jacobs
JA, Konstantinov
SR, Dejong
CH
&
Greve
JW (2004). Pretreatment with high-fat enteral nutrition reduces endotoxin and tumor necrosis factor-
and preserves gut barrier function early after hemorrhagic shock. Shock
21, 6571.[CrossRef][Medline]
Mikkelsen
LL, Naughton
PJ, Hedemann
MS
&
Jensen
BB (2004). Effects of physical properties of feed on microbial ecology and survival of Salmonella enterica serovar typhimurium in the pig gastrointestinal tract. Appl Envir Microbiol
70, 34853492.
Naughton
PJ, Mikkelsen
LL
&
Jensen
BB (2001). Effects of nondigestible oligosaccharides on Salmonella enterica serovar typhimurium and nonpathogenic Escherichia coli in the pig small intestine in vitro. Appl Envir Microbiol
67, 33913395.
Nieuwenhuijs VB, Verheem A, van Duijvenbode-Beumer H, Visser MR, Verhoef J, Gooszen HG & Akkermans LM (1998). The role of interdigestive small bowel motility in the regulation of gut microflora, bacterial overgrowth, and bacterial translocation in rats. Ann Surg 228, 188193.[CrossRef][Medline]
Ouwehand AC, Lagstrom H, Suomalainen T & Salminen S (2002). Effect of probiotics on constipation, fecal azoreductase activity and fecal mucin content in the elderly. Ann Nutr Metab 46, 159162.[CrossRef][Medline]
Pêna
JA, Rogers
AB, Ge
Z, Ng
V, Li
SY, Fox
JG
&
Versalovic
J (2005). Probiotic Lactobacillus spp. diminish Helicobacter hepaticus-induced inflammatory bowel disease in interleukin-10-deficient mice. Infect Immun
73, 912920.
Rada V, Sirotek K & Peter J (1999). Eveluation of selective media for bifidobacteria in poultry and rabbit caecal samples. Zentralbi Veterinarmed B 46, 369373.
Reeves
PG, Nielsen
FH
&
Fahey
GC (1993). AIN-93 Purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the recommendation of the AIN-76A rodent diet. J Nutr
123, 19391951.
Sarna SK (1989). In vivo myoelectric activity: methods, analysis, and interpretation. In Handbook of Physiology section 6, volume 1, part 4, chapter 21, ed. Schultz SG, Wood JD & Rauner BB, pp. 817863. American Physiological Society, Bethesda, MD, USA.
Scott LD & Cahall DL (1982). Influence of the interdigestive myoelectric complex on enteric flora in the rat. Gastroenterology 82, 737745.[Medline]
Soudah HC, Hasler WL & Owyang C (1991). Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma. N Engl J Med 325, 14611467.[Abstract]
Szurszewski
JH (1969). A migrating electric complex of canine small intestine. Am J Physiol
217, 17571763.
Szurszewski JH (1987). Electrical basis of gastrointestinal motility. In Physiology of Gastrointestinal Tract, 2nd edn, ed. Johnson LR, pp. 383422. Raven Press, New York.
Tsukada F, Saitoh M & Ohkubo Y (2000). Development of an experimental system for evaluation of the effect of stress on intestinal motility using a radionuclide, 51Cr, in the rat. Biol Pharm Bull 23, 13841386.[Medline]
Vantrappen G, Janssens J, Hellemans J & Ghoos Y (1977). The interdigestive motor complex of normal subjects and patients with bacterial overgrowth of the small intestine. J Clin Invest 59, 11581166.[Medline]
Weese JS, Anderson MEC, Lowe A & Monteith G (2003). Preliminary investigation of the probiotic potential of Lactobacillus rhamnosus strain GG in horses: fecal recovery following oral administration and safety. Can Vet J 44, 299302.[Medline]
Woodmansey
EJ, McMurdo
ME, Macfarlane
GT
&
Macfarlane
S (2004). Comparison of compositions and metabolic activities of fecal microbiotas in young adults and in antibiotic-treated and non-antibiotic-treated elderly subjects. Appl Environ Microbiol
70, 61136122.
Yajima
T (1985). Contractile effect of short-chain fatty acids on the isolated colon of the rat. J Physiol
368, 667678.
Yao YM, Yu Y, Sheng ZY, Tian HM, Wang YP, Lu LR & Yu Y (1995). Role of gut-derived endotoxaemia and bacterial translocation in rats after thermal injury: effects of selective decontamination of the digestive tract. Burns 21, 580585.[CrossRef][Medline]
| Acknowledgements |
|---|
This article has been cited by other articles:
![]() |
V. Lesniewska, I. Rowland, P. D. Cani, A. M. Neyrinck, N. M. Delzenne, and P. J. Naughton Effect on Components of the Intestinal Microflora and Plasma Neuropeptide Levels of Feeding Lactobacillus delbrueckii, Bifidobacterium lactis, and Inulin to Adult and Elderly Rats. Appl. Envir. Microbiol., October 1, 2006; 72(10): 6533 - 6538. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |